SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Calidi Presents CLD-401 Data and TCE Platform Advances at ESMO

Calidi said a single dose of CLD-401 induced tumor regression and complete responses in 80% of mice in an EMT6 breast tumor model.

CLDI

Related stories